Hormone pellets
This is not medical advice — it is general information based on what you searched for that may help.
General information based on published sources and the symptoms you searched for. This isn't medical or legal advice, a diagnosis or a treatment plan. Please consult a doctor about your own symptoms. If your symptoms are severe or sudden, seek urgent care.
Evidence:Not supported
Hormone pellets — small, hormone-containing implants inserted under the skin, typically releasing estrogen or testosterone over several months — are marketed as a convenient alternative to patches, gels, or pills. We don't recommend them, and here's the evidence-based reasoning.
Why we don't recommend pellets
Hormone pellets are almost always compounded products, meaning they're prepared by a compounding pharmacy rather than manufactured as an FDA-approved formulation. ACOG's 2023 clinical consensus specifically addresses compounded hormone products: it recommends against routinely prescribing them when FDA-approved formulations exist, and recommends that clinicians counsel patients on the lack of FDA approval and the risks specific to compounding if a patient wants one anyway. See our fuller explainer on bioidentical vs. compounded hormones for the full reasoning.
NICE guidance reaches a similar point from a different angle, recommending that patients be told plainly that the efficacy and safety of unregulated hormone preparations are unknown.
The specific problem with pellets as a delivery method
Beyond the compounding issue, pellets have a practical drawback that patches, gels, and pills don't: once inserted, a pellet releases its hormone dose over months without an easy way to adjust or stop it. If you have an adverse reaction or the dose turns out to be too high, you can't simply remove a patch or skip a pill — you're committed to that release schedule until it's naturally absorbed. Combined with compounding's lack of standardized dosing testing, this makes precise dose control harder than it needs to be.
What to ask about instead
FDA-approved patches, gels, and pills offer the same hormones with standardized testing and the ability to adjust or stop quickly if needed. If low libido is specifically what you're hoping a testosterone pellet would address, see our dedicated testosterone page for the FDA-unapproved-but-monitored alternative your clinician can offer instead. See also our policy page on products we won't recommend for the broader category this falls into, and our Does It Work? evidence directory for graded non-hormonal alternatives.
Use our treatment conversation builder to raise this directly with your clinician:
- Is there an FDA-approved patch, gel, or pill that would address my symptoms instead of a pellet?
- If I'm specifically interested in testosterone, what monitored, adjustable option exists instead of a pellet?
Where are you right now?
Still tracking
Not sure if your symptoms fit? Start tracking your daily patterns.
Log and spot your patterns with the symptom checklist →Ready to talk to a doctor
Have an upcoming appointment? Bring structured questions and your history.
Prepare your 10-minute doctor appointment questions →Already on treatment
Evaluating your response or wondering what to adjust next?
Explore evidence-graded treatment and lifestyle options →Questions people ask
Are hormone pellets safe?
Hormone pellets are typically compounded products, meaning they aren't FDA-approved and don't go through the same standardized testing for dosing accuracy as approved HRT formulations. ACOG recommends against routinely prescribing compounded hormone products when FDA-approved alternatives exist, specifically because of this gap.
Why would a pellet dose be a concern if the same hormones are in approved HRT products?
The hormone itself isn't automatically the issue — the delivery method is. Pellets release hormones over months without an easy way to adjust or stop the dose once inserted, unlike a patch you can remove or a pill you can stop taking. Combined with compounding's lack of standardized testing, this makes dosing harder to control precisely.
Related pages
References
- Compounded Bioidentical Menopausal Hormone Therapy: ACOG Clinical Consensus No. 6. American College of Obstetricians and Gynecologists' Committee on Clinical Consensus-Gynecology, 2023.
- Menopause: identification and management (NG23), Recommendations. National Institute for Health and Care Excellence (UK), 2026.
Change log
- : Published explainer on hormone pellets and why they're not recommended